Molecular Metabolism (May 2020)
‘Corrigendum to “Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia” [Molecular Metabolism 5 (2) (2015) 67–78]’
- Michaela Schäfer,
- Christian U. Oeing,
- Maria Rohm,
- Ezgi Baysal-Temel,
- Lorenz H. Lehmann,
- Ralf Bauer,
- H. Christian Volz,
- Michael Boutros,
- Daniela Sohn,
- Carsten Sticht,
- Norbert Gretz,
- Katrin Eichelbaum,
- Tessa Werner,
- Marc N. Hirt,
- Thomas Eschenhagen,
- Karin Müller-Decker,
- Oliver Strobel,
- Thilo Hackert,
- Jeroen Krijgsveld,
- Hugo A. Katus,
- Mauricio Berriel Diaz,
- Johannes Backs,
- Stephan Herzig
Affiliations
- Michaela Schäfer
- Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany
- Christian U. Oeing
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany
- Maria Rohm
- Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany
- Ezgi Baysal-Temel
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany
- Lorenz H. Lehmann
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany
- Ralf Bauer
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany
- H. Christian Volz
- Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany
- Michael Boutros
- Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany
- Daniela Sohn
- Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany
- Carsten Sticht
- Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany
- Norbert Gretz
- Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany
- Katrin Eichelbaum
- Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092, Berlin, Germany
- Tessa Werner
- Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany
- Marc N. Hirt
- Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany
- Thomas Eschenhagen
- Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany
- Karin Müller-Decker
- Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany
- Oliver Strobel
- Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany
- Thilo Hackert
- Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany
- Jeroen Krijgsveld
- Genome Biology Unit, EMBL, 69117, Heidelberg, Germany
- Hugo A. Katus
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany
- Mauricio Berriel Diaz
- Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany
- Johannes Backs
- Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany; Corresponding author. Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany. Tel.: +49 6221 5637714; fax: +49 6221 565573.
- Stephan Herzig
- Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany; Corresponding author. Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany. Tel.: +49 (0)89 3187 1046.
- Journal volume & issue
-
Vol. 35